Efficacy Study With 500 mg QD of TRO19622 vs Placebo in Patients With Painful Peripheral Diabetic Neuropathy

Mise à jour : Il y a 4 ans
Référence : NCT00496457

Femme et Homme

Extrait

The purpose of this study is to assess the efficacy and safety of TRO19622 administered PO daily for 6 weeks compared to placebo administered PO daily in patients with painful peripheral diabetic neuropathy.


Critère d'inclusion

  • Diabetic Neuropathy


Liens